3 results
Approved WMOCompleted
We propose a phase II study (intervention) in patients with severe generalized recessive dystrophic EB receiving reduced toxicity conditioning chemotherapy followe by cord blood transplantation with co-infusion of mesenchymal stromal cell units.…
Approved WMOCompleted
The objective of this validation study is to determine whether the wearable sensors: HealthPatch, SensiumVitals and the bed-based contact-less EarlySense system are able to detect heart rate and respiratory rate in a clinical setting, with…
Approved WMOWill not start
To evaluate the safety, tolerability and efficacy of IZD334 to reduce CRP in cardiovascular high-risk patients.